{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:05:56Z","timestamp":1757703956131,"version":"3.40.4"},"reference-count":47,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,2,9]]},"abstract":"<jats:p>A healthy 38-year-old woman developed sudden unilateral vision loss due to retrobulbar optic neuritis in the wake of varicella-zoster virus infection. She had no further central nervous system (CNS) lesions. Antinuclear antibodies (ANA) and anti-aquaporin 4 antibodies were found, consistent with neuromyelitis optica (NMO). Later, serial MRIs showed dynamic short-segment and long-segment myelitis lesions, ANA titre increased and additional autoantibodies were found including anti-dsDNA, anti-chromatin\/nucleosome and antiphospholipid antibodies. In that setting, NMO can be regarded a rare presenting manifestation of systemic lupus erythematosus (SLE). The relevant literature is reviewed and the implications of NMO spectrum disorder demyelinating syndromes as the first manifestation of SLE (with or without antiphospholipid syndrome) (APS) or their later development (in a patient diagnosed with SLE) as part of the spectrum of neuropsychiatric SLE are analysed in view of recent research developments in the field.<\/jats:p>","DOI":"10.1136\/bcr-2017-222158","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T14:15:35Z","timestamp":1520259335000},"page":"bcr-2017-222158","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["SLE presenting as demyelinative autoimmune visual loss"],"prefix":"10.1136","volume":"2018","author":[{"given":"Ami","family":"Schattner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilo","family":"Voichanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livnat","family":"Uliel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140188"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001126"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2013.07.010"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.6","first-page":"660","article-title":"Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature","volume":"126","author":"Cai","year":"2016","journal-title":"Int J Neurosci"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.9","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.2.204"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/jaut.2000.0484","article-title":"Can virus infections trigger Autoimmune Disease?","volume":"16","author":"Fujinami","year":"2001","journal-title":"J Autoimmun"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.09.013"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10072-006-0684-x","article-title":"Isolated bilateral anterior optic neuritis following chickenpox in an immunocompetent adult","volume":"27","author":"Galbussera","year":"2006","journal-title":"Neurol Sci"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.13","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2014.07.023","article-title":"Optic neuritis following Varicella zoster vaccination: report of two cases","volume":"32","author":"Han","year":"2014","journal-title":"Vaccine"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1203\/00006450-200109000-00009","article-title":"The Varicella-autoantibody syndrome","volume":"50","author":"Josephson","year":"2001","journal-title":"Pediatr Res"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014175"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.03.005"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamaneurol.2013.5055","article-title":"Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis","volume":"71","author":"Jiao","year":"2014","journal-title":"JAMA Neurol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.19","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.964"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.20","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn240"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050304"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ana.24608","article-title":"Clinicopathological features in anterior visual pathway in neuromyelitis optica","volume":"79","author":"Hokari","year":"2016","journal-title":"Ann Neurol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a6cb5c"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.021"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.26","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.17"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"Iyer","year":"2014","journal-title":"Autoimmunity"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.28","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311403344"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.29","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D\u2019Cruz","year":"2004","journal-title":"J Rheumatol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/03009740701218832","article-title":"Retrobulbar optic neuritis revealing primary anti-phospholipid antibody syndrome","volume":"36","author":"Marie","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.10.013"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.33","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu500oa"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.34","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.22305"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.36","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308097568"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of SLE patients","volume":"69","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka","year":"2013","journal-title":"PLoS One"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.01.011","article-title":"Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis","volume":"16","author":"Piga","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116378"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/368274","article-title":"The spectrum of anti-chromatin\/nucleosome autoantibodies: independent and interdependent biomarkers of disease","volume":"2014","author":"Mehra","year":"2014","journal-title":"J Immunol Res"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.42","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.5.431"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.43","first-page":"357","article-title":"Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study","volume":"52","author":"de Souza","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.025528"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7169-7"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/intimm\/dxx037","article-title":"Efficiency of antibody therapy in demyelinating diseases","volume":"29","author":"Akaishi","year":"2017","journal-title":"Int Immunol"},{"key":"2025042702575302000_2018.mar05_1.bcr-2017-222158.47","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0269-8"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-222158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T09:58:02Z","timestamp":1745747882000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-222158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":47,"alternative-id":["10.1136\/bcr-2017-222158"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-222158","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,3,5]]}}}